Brendan Smith is Chief Financial Officer of CRISPR Therapeutics AG.
Person profile
Roles
CRISPR Therapeutics
Chief Financial Officer
Address
Lexington, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
144
CRISPR Therapeutics AG
10 May 23
4
CRISPR Therapeutics AG
22 Feb 23
4
CRISPR Therapeutics AG
18 Oct 22
4
CRISPR Therapeutics AG
12 Oct 22
4
CRISPR Therapeutics AG
18 Aug 22
4
CRISPR Therapeutics AG
22 Feb 22
4
CRISPR Therapeutics AG
18 Oct 21
3
CRISPR Therapeutics AG
15 Oct 21
4
Translate Bio, Inc.
14 Sep 21
4
Translate Bio, Inc.
20 Apr 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
21 Feb 23 | CRSP CRISPR Therapeutics | Common Shares | Payment of exercise | Dispose F | No | No | 48.26 | 1,392 | 67.18 k | 5,072 |
18 Feb 23 | CRSP CRISPR Therapeutics | Common Shares | Option exercise | Acquire M | No | No | 0 | 3,825 | 0.00 | 6,464 |
18 Feb 23 | CRSP CRISPR Therapeutics | RSU Common Shares | Option exercise | Dispose M | No | No | 0 | 3,825 | 0.00 | 11,475 |
17 Oct 22 | CRSP CRISPR Therapeutics | Common Shares | Payment of exercise | Dispose F | No | No | 55.76 | 1,111 | 61.95 k | 2,639 |
14 Oct 22 | CRSP CRISPR Therapeutics | Common Shares | Option exercise | Acquire M | No | No | 0 | 3,750 | 0.00 | 3,750 |
14 Oct 22 | CRSP CRISPR Therapeutics | RSU Common Shares | Option exercise | Acquire M | No | No | 0 | 3,750 | 0.00 | 11,250 |
7 Oct 22 | CRSP CRISPR Therapeutics | Stock Option Common Shares | Grant | Acquire A | No | No | 61.65 | 14,000 | 863.10 k | 14,000 |